Grant - Oligomerix
Investment Firm
Overview
Oligomerix develops target identification and validation technologies enhancing the drug discovery process for neurodegenerative diseases.
Announced Date
Aug 09, 2022
Funding Type
Grant
Highlights
Location
New York, United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Oligomerix raised $3350000 on 2022-08-09 in Grant
Oligomerix develops target identification and validation technologies enhancing the drug discovery process for neurodegenerative diseases.
Company Funding History
8
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Apr 15, 2015 |  Venture Round - Oligomerix | - | 400.0K | |
| Sep 11, 2013 | Grant - Oligomerix | 1 | - | 1.7M |
| May 22, 2013 | Series B - Oligomerix | - | 2.8M | |
| Apr 23, 2012 | Series A - Oligomerix | 3 | - | 2.0M |
Recent Activity
There is no recent news or activity for this profile.